Appili Therapeutics Inc. (TSE:APL – Get Rating) – Zacks Small Cap issued their FY2023 earnings estimates for Appili Therapeutics in a note issued to investors on Thursday, July 14th. Zacks Small Cap analyst D. Bautz forecasts that the company will earn ($0.10) per share for the year. Zacks Small Cap also issued estimates for Appili Therapeutics' FY2024 earnings at ($0.07) EPS and FY2025 earnings at ($0.06) EPS.
Appili Therapeutics Stock Performance
Featured Articles
- Financial services firm Block stock has fallen (-59%) in 2022
- Hold Pfizer Today With Catalysts for Further Growth Tomorrow
- NVIDIA Stock is a Winding Up for a Record Setting Second Half
- Johnson & Johnson Continues to Prove its Value in a Volatile Year
- MarketBeat: Week in Review 7/11 – 7/15
Receive News & Ratings for Appili Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Appili Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.